Biotest Pharmaceuticals
Germany - Dreieich
PharmaceuticalFocus: Biologics
Biotest Pharmaceuticals is a life sciences company focused on Biologics.
Neurology
Open Jobs
0
Pipeline & Clinical Trials
Kidney transplantation
Renal Failure, ChronicFVIII Concentrates
Severe Hemophilia AVWF/FVIII concentrates
Severe Hemophilia AUSB005
Healthy VolunteersClinical Trials (1)
NCT03615196Study of the Safety of USB005 in Healthy Volunteers
Phase 1BT062
Multiple MyelomaClinical Trials (1)
NCT00723359Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Phase 1Angiotensin 1-7
HIV InfectionsClinical Trials (1)
NCT00757250Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
Phase 1SOR007 Ointment 2.0%
Plaque PsoriasisClinical Trials (1)
NCT03004339Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
Phase 1NanoDoce
Renal Cell CarcinomaClinical Trials (1)
NCT04260360Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma
Phase 1IgM-enriched Intravenous Immunoglobulins
PolyneuropathiesClinical Trials (1)
NCT01867645The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
Phase 1BT062 , intravenous administration
Multiple MyelomaClinical Trials (1)
NCT01638936BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma
Phase 1/2Hepatitis B Immune Globulin
Hepatitis B Virus Associated Liver DiseaseClinical Trials (1)
NCT01421212Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Phase 1/2SOR007
Cutaneous MetastasisClinical Trials (1)
NCT03101358Study of Topical SOR007 Ointment for Cutaneous Metastases
Phase 1/2BT062
Multiple MyelomaClinical Trials (1)
NCT01001442Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Phase 1/2NanoDoce
Bladder CancerClinical Trials (1)
NCT03636256Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
Phase 1/2BT061
Psoriasis VulgarisClinical Trials (1)
NCT01072383Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Phase 2Phase 2
Clinical Trials (1)
NCT04778059Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
Phase 2NanoPac®
Adenocarcinoma of the ProstateClinical Trials (1)
NCT03077659Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer
Phase 2Tregalizumab
Rheumatoid ArthritisTrimodulin
Covid19Clinical Trials (1)
NCT04576728Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19
Phase 2Cytotect
Kidney TransplantationClinical Trials (1)
NCT04934527Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
Phase 2Cytotect®CP
Cytomegalovirus InfectionsClinical Trials (1)
NCT05370976Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.
Phase 2SOR007
Actinic KeratosisClinical Trials (1)
NCT03083470Study of SOR007 Ointment for Actinic Keratosis
Phase 2Pentaglobin®/Standard of Care
PeritonitisClinical Trials (1)
NCT03334006Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis
Phase 2NorLeu3-A
Foot Ulcer, DiabeticClinical Trials (1)
NCT00796744Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
Phase 2Phase 2
Clinical Trials (1)
NCT03143491Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)
Phase 2NanoPac
Lung Cancer, Nonsmall CellClinical Trials (1)
NCT04314895Trial of NanoPac Intratumoral Injection in Lung Cancer
Phase 2Phase 2
Clinical Trials (1)
NCT03077685Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
Phase 2Phase 2
Clinical Trials (1)
NCT02554019Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus
Phase 2NanoPac
Prostate CancerClinical Trials (1)
NCT04221828Trial of NanoPac Focal Therapy for Prostate Cancer
Phase 2NanoPac® 100 mg/m2
Ovarian CarcinomaClinical Trials (1)
NCT03029585Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer
Phase 2Human hepatitis B Immunoglobulin
Chronic Hepatitis BClinical Trials (1)
NCT05345990Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins
Phase 2Phase 2
Clinical Trials (1)
NCT01420744Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP
Phase 2BT061
Rheumatoid ArthritisClinical Trials (1)
NCT01481493Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)
Phase 2Phase 2
Clinical Trials (1)
NCT03188991Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
Phase 2Trimodulin
Community-acquired PneumoniaClinical Trials (1)
NCT05722938Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Phase 3Phase 3
Clinical Trials (1)
NCT02065882Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
Phase 3IgG Next Generation
Primary Immunodeficiency DiseaseClinical Trials (1)
NCT02810444Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Phase 3Phase 3
Clinical Trials (1)
NCT05170269Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
Phase 3Zutectra
Hepatitis BClinical Trials (1)
NCT01856413A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Phase 3BT524
Bleeding DisorderClinical Trials (1)
NCT03444324Adjusted Fibrinogen Replacement Strategy
Phase 3Phase 3
Clinical Trials (1)
NCT02859909This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)
Phase 3Trimodulin
Respiratory InfectionClinical Trials (1)
NCT05531149Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
Phase 3Nabi-HB
Hepatitis B, ChronicClinical Trials (1)
NCT00800787Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation
Phase 3Civacir® 10%
Hepatitis C InfectionClinical Trials (1)
NCT01804829Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 40 clinical trials